Instituto Bernabeu S.L. — Sponsor Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

6 Unique IMPs

N/A Results reported

Phase III

Phase IV

Top IMPs

3 total

TRAP study: Testosterone for Androgen Receptor Polymorphism. Not authorised

2024-510596-37-00 Phase IV 1 country FOLLITROPIN ALFA; GANIRELIX; TESTOSTERONE; TRIPTORELIN
TRAP study: Testosterone for Androgen Receptor Polymorphism. Pending

2024-510596-37-01 Phase III 1 country FOLLITROPIN ALFA; GANIRELIX; TESTOSTERONE; TRIPTORELIN
PRO_NAT Recruiting

2023-504188-18-00 Phase IV 1 country FOLLITROPIN ALFA; FOLLITROPIN ALFA (GENETICAL RECOMBINATION); GANIRELIX; PROGEST…

Showing 1–3 of 3 trials